维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Jackman AL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer显示文摘	Jackman D Pao W Riely GJ ct al	2010	J Clin Oncol2010，28，2：	1
2	Combination of raltitrexed with other cytotoxic agents : rationale and preclinical observations 显示文摘	Jackman AL Kimbell R Ford HE	1999	Eur J Cancer1999，35，1：	1
3	ZD1694 (Tomudex) : a new thymidylate synthase inhibitor with activity in colorectal cancer 显示文摘	Jackman AL Farrugia DC Gibson W	1995	Eur J Cancer1995，31，78：	1
4	Combination of raltitrexed with other cytotoxic agent: rational and preclinical observations显示文摘	Jackman AL Kimbell R Ford HE	1999	Eur J Cancer1999，35，1：	1
5	The role of α-folate receptor-mediated transport in the antitumor activity of antifolate drugs显示文摘	Theti DS Jackman AL	2004	Clin Cancer Res2004，10，：	1
6	The 'mini - pere' teeh nigue: a less invasive alternate to pereutaneousnephrolithoto- nay 显示文摘	Jackman SV DoeimoSG Cadeddu JA et al	1998	World J Urol1998，16，：	1
7	Mechanism of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex)in one mouse and three human cell lines显示文摘	KELLAND LR KIMBELL R	1995	Br J Cancer1995，71，5：	1
8	Antifolates targeted specifical- ly to the 5olate reeeptor显示文摘	Jackman AL Theti DS Gibbs DD	2004	Adv Drug Deliv Rev2004，56，8：	1
9	ZD1694(Tomudex):a new thymidylate synthase inhibitor with activity in colorectal cancer显示文摘	Jackman AL Farrugia DC Gibson W	1995	Eur J Cancer1995，31，78：	1
10	Combination of raltitrexed with other cytotoxic agents:rationale and preclinical observa- tions 显示文摘	Jackman AL Kimbell R Ford HE	1999	Eur J Cancer1999，35，1：	1
11	Quinazoline antifolate thymidylate synthase inhibitors: Alkyl, substituted Alkly, and Aryl substituents in the C2 position显示文摘	Hughes RL Jackman AL Oldfield J	1999	J Med Chem1999，33，11：	1
12	A rationale for the clinical development of the thymdylate synthase inhibitor ZD9331 in ovarian and other solid tumours 显示文摘	Jackman AL Melin CJ Kimbell R	2002	Biochim Biophys Acta2002，1587，7：	1
13	Expression of vascular permeability factor( vascular endothelial groth factor) and itsreeeptor in breast cancer显示文摘	BROWN L BRASE B JACKMAN R ct al	1995	Am J Path1995，142，2：	1
14	ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent of L 1210 tumor cell growth in vitro and in vivo: a new agent for clinical study显示文摘	TAYLOR GA GIBSON W	1991	Cancer Res1991，51，20：	1
15	A rationale for the clinical development of the thymdylate synthase inhibitor ZD9331 in ovarian and other solid tumours显示文摘	Jackman AL Melin CJ Kimbell R	2002	Biochim Biophys Acta2002，1587，7：	1
16	Combination of raltit- rexed with other cytotoxic agents: rationale and preclinical obser- vations显示文摘	Jackman AL Kimbell R Ford HE	1999	Eur J Cancer1999，35，1：	1
17	Combination of raltitrexed with other cytotoxic agent : rationale and preclinical observations 显示文摘	Jackman AL Kimbell R Ford HE	1999	EurJ Cancer1999，35，1：	1
18	Combination of raltitrexed with other cytotoxic agents:Rationale and preclinical observations显示文摘	Jackman AL Kimbell R Ford HE	1999	Eur J Cancer1999，35，1：	1
19	Quinazoline antifolate thymidylate synthase inhibitors:heterocyclic benzoyl ring modifications显示文摘	Marsham PR Hughes LR Jackman AL	1991	J Med Chem1991，34，：	1
20	Combination of rahitrexed with other cytotoxic agents: rationale and preclinical observations 显示文摘	Jackman AL Kimbell R Ford HE	1999	Eur J Cancer1999，35，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示